CoreAge Rx vs Remi Meds
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Remi Meds head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 57 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make Remi Meds a bad call — it's best for people considering a personalized weight-care program who obtain the actual ingredient, prescription label, complete payment and pharmacy instructions. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | Remi Meds |
|---|---|---|
| Brief Score | 94/100 (A) | 57/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Named ingredient and full quote unconfirmed Current GLP-1/GIP+B12 weekly-dose labels: 2.25 mg $349/mo, 4.5 mg $379, 6.75 mg $429, 9 mg $549, 11.25 mg $639. Active ingredient not spelled out in the current offer; obtain label, quantity and full fee scope. FAQ: billed at shipment; submitted orders cannot be canceled. Future-refill account controls do not promise a current-order refund; dispensed/carrier-handed drugs final sale. Confirm storage with pharmacy. Full price detailsCurrent named semaglutide prescription and complete medication quote unknown; current public offer is GLP-1/GIP plus B12 with dose-linked monthly figures $349–$639, exact active ingredient and supplied quantity need confirmation |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | Named ingredient and full quote unconfirmed Current GLP-1/GIP+B12 weekly-dose labels: 2.25 mg $349/mo, 4.5 mg $379, 6.75 mg $429, 9 mg $549, 11.25 mg $639. Active ingredient not spelled out in the current offer; obtain label, quantity and full fee scope. FAQ: billed at shipment; submitted orders cannot be canceled. Future-refill account controls do not promise a current-order refund; dispensed/carrier-handed drugs final sale. Confirm storage with pharmacy. Full price detailsCurrent named tirzepatide prescription and complete medication quote unknown; current public offer is GLP-1/GIP plus B12 with dose-linked monthly figures $349–$639, exact active ingredient and supplied quantity need confirmation |
| Coverage | US only; restrictions by state, confirmed at intake | FAQ advertises nationwide service with location-specific clinical requirements; actual provider and dispensing-pharmacy eligibility still need confirmation |
| Brand-name access | Not confirmed | The site disclaims supplying the referenced manufactured brands; the current class-labeled blend still needs exact ingredient and preparation confirmation. |
| Oral / sublingual | Injection only | Unconfirmed |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
Remi Meds: Current GLP-1/GIP+B12 program $349–$639 by displayed weekly-dose tier; named ingredient/full quote unconfirmed. FAQ bills at shipment and treats submitted orders as noncancelable; future-refill controls are separate.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.